Rabbit Polyclonal JNK1 antibody. Suitable for IHC-P, WB and reacts with Rat, Human, Mouse samples. Cited in 34 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK8.
Preservative: 0.025% Sodium azide, 0.025% Thimerosal (merthiolate)
Constituents: 2.5% BSA, 0.45% Sodium chloride, 0.1% Disodium hydrogenorthophosphate
IHC-P | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Expected |
Rat | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info 0.5-1 µg/mL | Notes Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species Human | Dilution info 0.5-1 µg/mL | Notes Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 0.5-1 µg/mL | Notes Perform heat-mediated antigen retrieval before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info 0.1-0.5 µg/mL | Notes - |
Species Human | Dilution info 0.1-0.5 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 0.1-0.5 µg/mL | Notes - |
Select an associated product type
Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed:28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:18307971). Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins (PubMed:21856198). Loss of this interaction abrogates the acetylation required for replication initiation (PubMed:21856198). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1 (PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation (PubMed:21095239). Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy (PubMed:18570871). Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons (By similarity). In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH (PubMed:16581800, PubMed:17296730, PubMed:20027304). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates the heat shock transcription factor HSF1, suppressing HSF1-induced transcriptional activity (PubMed:10747973). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates JUND and this phosphorylation is inhibited in the presence of MEN1 (PubMed:22327296). In neurons, phosphorylates SYT4 which captures neuronal dense core vesicles at synapses (By similarity). Phosphorylates EIF4ENIF1/4-ET in response to oxidative stress, promoting P-body assembly (PubMed:22966201). Phosphorylates SIRT6 in response to oxidative stress, stimulating its mono-ADP-ribosyltransferase activity (PubMed:27568560). Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (PubMed:28943315). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572). JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms.
MAPK9
JNK1, PRKM8, SAPK1, SAPK1C, MAPK8, Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, JNK-46, Stress-activated protein kinase 1c, Stress-activated protein kinase JNK1, c-Jun N-terminal kinase 1, SAPK1c
Rabbit Polyclonal JNK1 antibody. Suitable for IHC-P, WB and reacts with Rat, Human, Mouse samples. Cited in 34 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK8.
Preservative: 0.025% Sodium azide, 0.025% Thimerosal (merthiolate)
Constituents: 2.5% BSA, 0.45% Sodium chloride, 0.1% Disodium hydrogenorthophosphate
JNK1 and JNK2 are part of the c-Jun N-terminal kinase group also called Stress-activated protein kinases (SAPKs). These proteins are serine/threonine kinases with a known molecular weight around 46-54 kDa depending on their phosphorylation state. JNK1 and JNK2 phosphorylate specific target proteins which include transcription factors and other kinases to regulate various cellular processes. They are expressed in most tissues with higher levels in brain heart and skeletal muscle. JNK isoforms have become essential in research involving stress responses where specific tools such as JNK antibodies and Western blot assays targeting p-JNK molecular weight are critical for study.
These enzymes play vital roles in regulating cellular responses to stress stimuli. JNK1 and JNK2 form part of larger signaling complexes including the JNK molecular weight complex that is activated in stressful conditions like UV radiation or cytokines. Once activated they phosphorylate transcription factors such as c-Jun leading to gene expression changes that facilitate adaptative and survival responses. They modulate cellular processes like apoptosis inflammation and cell differentiation clearly contributing to homeostasis and development.
These kinases interact significantly within the MAPK (Mitogen-activated protein kinase) and apoptosis pathways. JNK proteins mediate signals from upstream kinases such as MKK4/7 and respond to inflammatory cytokines resulting in transcriptional alterations. Their downstream impact is tightly linked to apoptosis through interactions with Bcl-2 family members affecting cellular fate. ERK and p38 MAPK proteins closely interact with JNK pathways co-regulating cellular stress responses and survival pathways highlighting their importance in maintaining cellular balance.
The altered regulation of JNK1 and JNK2 links them to diverse conditions such as cancer and neurodegenerative diseases. In cancer abnormal JNK activity affects cell proliferation and apoptosis with JNK pathways often hyperactivated in tumors. In neurodegeneration these kinases contribute to cell death as seen in disorders like Alzheimer's disease where they engage with proteins like tau leading to neuronal apoptosis. The connection of JNK proteins to other stress-activated kinases further positions them as critical therapeutic targets in disease modulation.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-JNK1 + JNK2 antibody (ab112501)
Lane 1: Rat brain tissue lysate
Lane 2: Rat thymus tissue lysate
Lane 3: MCF-7 whole cell lysate
Lane 4: HeLa whole cell lysate
Lane 5: Jurkat whole cell lysate
Lane 6: MM231 whole cell lysate
Lane 7: 6T-CEM whole cell lysate
Predicted band size: 48 kDa
Observed band size: 55 kDa
ab112501 staining JNK1+JNK2 in Human intestinal cancer tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
ab112501 staining JNK1+JNK2 in Rat intestinal tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
Image collected and cropped by CiteAb under a CC-BY license from the publication
JNK1 + JNK2 western blot using anti-JNK1 + JNK2 antibody ab112501. Publication image and figure legend from Yang, C., Yan, Z., et al., 2020, Cancer Cell Int, PubMed 32015692.
ab112501 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab112501 please see the product overview.
miR-517a inhibition suppressed activation of the JNK signaling pathway by targeting CDKN1C. a Binding of miR-517a to CDKN1C confirmed by dual-luciferase reporter assay; *p < 0.05 compared with cells treated with empty vector. b miR-517a expression and mRNA level of CDKN1C in cells detected using RT-qPCR. c, d Western blot analysis of CDKN1C, JNK, and p38 proteins in cells. *p < 0.05 compared with cells without treatment; #p < 0.05 compared with cells treated with NC inhibitor; &p < 0.05, compared with the cells treated with pcDNA-NC. All data were expressed as mean ± standard deviation; comparisons among multiple groups were analyzed by one-way ANOVA; the experiment was repeated three times
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com